About
Flavia H. Pease served as Corporate Executive Vice President and Chief Financial Officer of Charles River Laboratories. On September 12, 2025, she informed the Company of her intention to resign from her position as Corporate Executive Vice President, Chief Financial Officer, effective September 29, 2025. The Company disclosed that her decision to resign was not the result of any disagreements with the Company on any matter relating to its financial statements, internal control over financial reporting, operations, policies or practices. Upon her departure, Michael G. Knell was appointed interim Chief Financial Officer.
Roles
Charles River Laboratories International, Inc.
Former Corporate Executive Vice President and Chief Financial Officer · Current role
until September 2025–present
Charles River Laboratories International, Inc.
Corporate Executive Vice President and Chief Financial Officer · Resigned effective September 29, 2025.
until Sep 2025
Johnson & Johnson
Vice President and Group Chief Financial Officer, global Medical Devices
2019-2022
Janssen (Johnson & Johnson)
Vice President of Finance, North America
—
Fixed Compensation
FY 2025Salary
$507,692
ComponentAnnual base salary
All other compensation
$35,457
Total compensation
$2,952,695
Performance Compensation
Data from FY 2025Stock awards
Stock awards
$2,409,546
FormRSUs and PSUs
Also at Charles River Laboratories International, Inc.
Colleague
James C. Foster
Chair, President and Chief Executive Officer
Colleague
Birgit Girshick
Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026)
Colleague
Nancy C. Andrews
Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital)
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.